tradingkey.logo

ASP Isotopes Inc

ASPI
查看詳細走勢圖
5.911USD
-0.039-0.66%
交易中 美東報價延遲15分鐘
551.91M總市值
虧損本益比TTM

ASP Isotopes Inc

5.911
-0.039-0.66%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.66%

5天

+3.88%

1月

-0.99%

6月

-19.14%

今年開始到現在

+30.48%

1年

+29.62%

查看詳細走勢圖

TradingKey ASP Isotopes Inc股票評分

單位: USD 更新時間: 2025-12-23

操作建議

ASP Isotopes Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在藥品行業排名78/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價13.00。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

ASP Isotopes Inc評分

相關信息

行業排名
78 / 158
全市場排名
184 / 4568
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 3 分析師
買入
評級
13.000
目標均價
+112.42%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

ASP Isotopes Inc亮點

亮點風險
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
業績增長期
公司處於發展階段,最新年度總收入4.14M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入4.14M美元
估值合理
公司最新PE估值-4.26,處於3年歷史合理位
機構加倉
最新機構持股55.02M股,環比增加0.24%
保羅都鐸瓊斯持倉
明星投資者保羅都鐸瓊斯持倉,最新持倉460.69K股

ASP Isotopes Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

ASP Isotopes Inc簡介

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
公司代碼ASPI
公司ASP Isotopes Inc
CEOAinscow (Robert)
網址https://aspisotopes.com/

常見問題

ASP Isotopes Inc(ASPI)的當前股價是多少?

ASP Isotopes Inc(ASPI)的當前股價是 5.911。

ASP Isotopes Inc 的股票代碼是什麼?

ASP Isotopes Inc的股票代碼是ASPI。

ASP Isotopes Inc股票的52週最高點是多少?

ASP Isotopes Inc股票的52週最高點是14.490。

ASP Isotopes Inc股票的52週最低點是多少?

ASP Isotopes Inc股票的52週最低點是3.650。

ASP Isotopes Inc的市值是多少?

ASP Isotopes Inc的市值是551.91M。

ASP Isotopes Inc的淨利潤是多少?

ASP Isotopes Inc的淨利潤為-35.11M。

現在ASP Isotopes Inc(ASPI)的股票是買入、持有還是賣出?

根據分析師評級,ASP Isotopes Inc(ASPI)的總體評級為買入,目標價格為13.000。

ASP Isotopes Inc(ASPI)股票的每股收益(EPS TTM)是多少

ASP Isotopes Inc(ASPI)股票的每股收益(EPS TTM)是-1.398。
KeyAI